Does Bill Ackman Feel Humiliated When Herbalife Shares Rise?

Photo of Chris Lange
By Chris Lange Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Herbalife Ltd. (NYSE: HLF) was under attack yet again on Friday morning by activist investor Bill Ackman on an appearance on CNBC’s “Squawk Box.” However, despite stating his case against the giant nutrition company, shares of Herbalife shares rallied before the opening bell. The rally almost feels like it was out of spite.

Ackman has been waging an outright war against Herbalife for over two years now, since he took up a short position. He has had conferences, presentations and other demonstrations against Herbalife, calling it a criminal enterprise and pyramid scheme.

The reason for coming on the show was to defend himself after reports that there has been market manipulation around Herbalife shares. While there is an ongoing investigation into the stock manipulation, Ackman said that he has not been personally contacted by investigators in this instance.

Jacob Frenkel, a former federal prosecutor, commented on the situation in a separate CNBC interview:

In terms of what he has said so far, it may be borderline manipulative, but it does not yet appear to be stock manipulation because a lot of the statements he’s making are general statements, but they are conclusory.

ALSO READ: Activist Investor Comes in to Save Lumber Liquidators

Previously, Herbalife did come under observation by the Federal Trade Commission just a year ago. The company may be exonerated in the probe, according to Bloomberg. However, this probe came after Ackman accused Herbalife of misleading distributors, misrepresenting sales figures and selling a commodity product at inflated prices.

The real reason Herbalife stock is up in Friday’s trading session is not really to spite Ackman or because he plans to hit the interview circuit with his campaign against the company. The rally is likely being pinned on the news that the government is looking into whether the market or stock was manipulated. Depending on that outcome, this could prove costly to Ackman in more ways than one.

Shares of Herbalife closed up 0.5% at $33.25 on Thursday. In premarket trading Friday, shares went up another 5.7% to $35.15, and shortly after the open the shares were up 8.1% at $35.94. The stock has a consensus analyst price target of $57.80 and a 52-week trading range of $27.60 to $69.69.

Is it irony or paradox when a short seller gets to state his case with such strong conviction and the stock rises?

ALSO READ: The Best (and Worst) States for Business

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618